Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (2.796)

1

Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy : a multicenter randomized controlled study

enthalten in: BMC cancer | 2019

von Lu, Y. | Chen, D. | Liang, J. | +8

2

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer : A Retrospective Bi-centric Cohort Study

enthalten in: Targeted oncology | 2019

von Lang, D. | Huemer, F. | Rinnerthaler, G. | +9

3

Late phase II/III study of BYM338 in patients with sporadic inclusion body myositis (RESILIENT) : Japanese cohort data

enthalten in: Rinsho shinkeigaku = Clinical neurology | 2019

von Mori-Yoshimura, M. | Yamashita, S. | Suzuki, N. | +7

4

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Oncology | 2019

von Nakagawa, K. | Garon, E. | Seto, T. | +118

CommentIn: Lancet Oncol. 2019 Dec;20(12):1617-1618. - PMID 31591061

5

The combination of granulocyte-monocyte apheresis and vedolizumab : A new treatment option for ulcerative colitis?

enthalten in: Journal of clinical apheresis | 2019

von Rodríguez-Lago, I. | Benítez, J. | Sempere, L. | +4

6

Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma : a post-marketing surveillance study

enthalten in: Japanese journal of clinical oncology | 2019

von Motoo, N. | Hayashi, Y. | Shimizu, A. | +2

7

Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA

enthalten in: Immunotherapy | 2019

von Huang, M. | Lopes, G. | Insinga, R. | +4

8

Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol : a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial

enthalten in: BMJ open | 2019

von Jones, A. | Muller, P. | Dore, C. | +6

9

FDA Approval Summary : Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Kasamon, Y. | Chen, H. | de Claro, R. | +5

CommentIn: Clin Cancer Res. 2019 Dec 15;25(24):7272-7274. - PMID 31615932

10

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia : A Phase 3, Single-Arm, International Trial

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2019

von Insogna, K. | Rauch, F. | Kamenický, P. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[280]